Balachandran Madhavan — SEC Form 4 filings
SEC reporting owner CIK 1555508. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-17 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 6 filings — 29,514 shares, $926,372 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 10,000 shares @ $27.85 ($278,500) in uniQure N.V., filed 2026-06-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| uniQure N.V. (QURE) | Director | 7 | — | 7 legs · 28,021 sh · $900,856 | 12 |
| Stevanato Group S.p.A. (STVN) | Director | 1 | — | 1 leg · 1,493 sh · $25,515 | 1 |
| Replimune Group, Inc. (REPL) | Director | 3 | — | — | 3 |
Form 4 filings — Balachandran Madhavan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Stevanato Group S.p.A. (STVN) | Grant/award (A): 4,975 @ $0 · Sale (S): 1,493 @ $17.09 | EDGAR |
| 2026-06-22 | 4 | uniQure N.V. (QURE) | Option exercise (M): 5,295 @ $31.71 · Option exercise (M): 6,390 @ $19.39 · Sale (S): 5,295 @ $47.08 · Sale (S): 4,700 @ $43.66 · Sale (S): 1,690 @ $42.60 · Option exercise (M): 5,295 (derivative) @ $0 · +1 more | EDGAR |
| 2026-06-17 | 4 | uniQure N.V. (QURE) | Option exercise (M): 10,000 @ $8.49 · Sale (S): 10,000 @ $27.85 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | uniQure N.V. (QURE) | Grant/award (A): 7,550 @ $0 · Sale (S): 1,993 @ $27.06 · Grant/award (A): 13,980 (derivative) @ $0 | EDGAR |
| 2026-04-07 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 44,500 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | uniQure N.V. (QURE) | Sale (S): 2,112 @ $14.45 | EDGAR |
| 2025-06-13 | 4 | uniQure N.V. (QURE) | Grant/award (A): 7,970 @ $0 · Grant/award (A): 15,630 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Replimune Group, Inc. (REPL) | Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | uniQure N.V. (QURE) | Grant/award (A): 8,080 @ $0 · Grant/award (A): 15,840 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | uniQure N.V. (QURE) | Sale (S): 2,231 @ $5.12 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1555508 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →